Home LiteratureArticle Details
PMID: 6238434 Published · ppublish English Comparative Study Journal Article Research Support, U.S. Gov't, P.H.S. Review

The chemistry and biology of complement receptors.

Springer seminars in immunopathology ·Vol. 7 ·No. 2-3 ·1984-00-00 ·Pages 221-49

Schreiber RD

Abstract

暂无摘要

MeSH Terms
Animals Complement Activating Enzymes Complement C1q Complement C3b Inactivator Proteins Complement C5 Complement C5a Complement Factor H Humans Immunochemistry Macrophage-1 Antigen Receptors, Complement/physiology
Chemicals
CFH protein, human Complement C3b Inactivator Proteins Complement C5 Macrophage-1 Antigen Receptors, Complement Complement C1q Complement C5a Complement Factor H Complement Activating Enzymes
Authors & Affiliations
1 authors, click to expand affiliations / ORCID
Schreiber R D
References (121)
121 references, click to expand
  1. Recurrent infections and delayed separation of the umbilical cord in an infant with abnormal phagocytic cell locomotion and oxidative response during particle phagocytosis.
    J Pediatr. 1981 Dec;99(6):887-94 PMID: 7310581
  2. Potentiation of antiboty-dependent cell-mediated cytotoxicity by target cell-bound C3b.
    J Immunol. 1979 Sep;123(3):1285-8 PMID: 469251
  3. Activation and regulation of the first complement component.
    Fed Proc. 1983 Jan;42(1):134-8 PMID: 6848374
  4. Isolation of lymphocyte membrane complement receptor type two (the C3d receptor) and preparation of receptor-specific antibody.
    Proc Natl Acad Sci U S A. 1981 Mar;78(3):1828-32 PMID: 6101236
  5. The immune adherence receptor: dissociation between the expression of erythrocyte and mononuclear cell C3b receptors.
    J Immunol. 1975 Nov;115(5):1312-5 PMID: 1100727
  6. The immune-adherence phenomenon; an immunologically specific reaction between microorganisms and erythrocytes leading to enhanced phagocytosis.
    Science. 1953 Dec 18;118(3077):733-7 PMID: 13122009
  7. Functional properties of membrane-associated complement receptor CR1.
    J Immunol. 1983 Apr;130(4):1876-80 PMID: 6220069
  8. Complement-induced granulocyte aggregation: an unsuspected mechanism of disease.
    N Engl J Med. 1980 Apr 3;302(14):789-94 PMID: 6986559
  9. Influence of the Escherichia coli capsule on complement fixation and on phagocytosis and killing by human phagocytes.
    J Clin Invest. 1980 Jan;65(1):82-94 PMID: 6985617
  10. Increased expression of C3b receptors on polymorphonuclear leukocytes induced by chemotactic factors and by purification procedures.
    J Immunol. 1983 Jan;130(1):370-5 PMID: 6847888
  11. Depletion of plasma complement in vivo by a protein of cobra venom: its effect on various immunologic reactions.
    J Immunol. 1970 Jul;105(1):55-69 PMID: 4246566
  12. Characteristics of isolated erythrocyte complement receptor type one (CR1, C4b-C3b receptor) and CR1-specific antibodies.
    J Immunol. 1981 Feb;126(2):693-8 PMID: 7005341
  13. Cross-reaction of a rat-anti-mouse phagocyte-specific monoclonal antibody (anti-Mac-1) with human monocytes and natural killer cells.
    J Immunol. 1981 Jan;126(1):359-64 PMID: 7451976
  14. The sequential appearance of Ia-like antigens and two different complement receptors during the maturation of human neutrophils.
    J Exp Med. 1978 Mar 1;147(3):730-44 PMID: 273062
  15. Activation of human monocytes by both human beta 1H and C3b.
    Immunology. 1982 Jun;46(2):307-12 PMID: 6211407
  16. Induction of interleukin 1 secretion and enhancement of humoral immunity by binding of human C5a to macrophage surface C5a receptors.
    J Exp Med. 1982 Sep 1;156(3):912-7 PMID: 6809882
  17. Release of endogenous C3b inactivator from lymphocytes in response to triggering membrane receptors for beta 1H globulin.
    J Exp Med. 1980 Dec 1;152(6):1625-44 PMID: 6450259
  18. Detection of circulating immune complexes by using human red blood cells.
    J Lab Clin Med. 1979 Dec;94(6):902-16 PMID: 387898
  19. Complement receptor binding of C3b-coated cells treated with C3b inactivator, beta 1H globulin and trypsin.
    J Immunol. 1979 Aug;123(2):523-8 PMID: 88474
  20. Deficiency of a granulocyte-membrane glycoprotein (gp150) in a boy with recurrent bacterial infections.
    N Engl J Med. 1982 Mar 25;306(12):693-9 PMID: 6278303
  21. Polymorphism of human erythrocyte C3b/C4b receptor.
    Proc Natl Acad Sci U S A. 1983 Mar;80(6):1698-702 PMID: 6572933
  22. Induction of thromboxane release from macrophages by anaphylatoxic peptide C3a of complement and synthetic hexapeptide C3a 72-77.
    J Immunol. 1983 Mar;130(3):1345-9 PMID: 6600482
  23. Primate erythrocyte-immune complex-clearing mechanism.
    J Clin Invest. 1983 Feb;71(2):236-47 PMID: 6822663
  24. Two different complement receptors on human lymphocytes. One specific for C3b and one specific for C3b inactivator-cleaved C3b.
    J Exp Med. 1973 Oct 1;138(4):798-811 PMID: 4542735
  25. Complement ligand-receptor interactions that mediate biological responses.
    Annu Rev Immunol. 1983;1:243-71 PMID: 6242465
  26. The beta-Cys-gamma-Glu thiolester bond in human C3, C4, and alpha 2-macroglobulin.
    Springer Semin Immunopathol. 1983;6(4):259-82 PMID: 6198737
  27. Native C3 does not bind to the C3b receptor (CR1) of human blood B lymphocytes or alter immunoglobulin synthesis.
    J Immunol. 1983 Mar;130(3):1021-3 PMID: 6600466
  28. Paroxysmal nocturnal hemoglobinuria: deficiency in factor H-like functions of the abnormal erythrocytes.
    J Exp Med. 1983 Jun 1;157(6):1971-80 PMID: 6222136
  29. Generation of three different fragments of bound C3 with purified factor I or serum. II. Location of binding sites in the C3 fragments for factors B and H, complement receptors, and bovine conglutinin.
    J Exp Med. 1983 Aug 1;158(2):334-52 PMID: 6224880
  30. Requirement for human red blood cells in inactivation of C3b in immune complexes and enhancement of binding to spleen cells.
    J Immunol. 1983 Mar;130(3):1336-40 PMID: 6218206
  31. Bone-marrow transplantation for inborn error of phagocytic cells associated with defective adherence, chemotaxis, and oxidative response during opsonised particle phagocytosis.
    Lancet. 1983 Aug 27;2(8348):473-6 PMID: 6136643
  32. Isolation of a human erythrocyte membrane glycoprotein with decay-accelerating activity for C3 convertases of the complement system.
    J Immunol. 1982 Jul;129(1):184-9 PMID: 6211481
  33. The alternative pathway of complement.
    Springer Semin Immunopathol. 1984;7(2-3):163-92 PMID: 6238433
  34. Breakdown of C3 after complement activation. Identification of a new fragment C3g, using monoclonal antibodies.
    J Exp Med. 1982 Jul 1;156(1):205-16 PMID: 6177820
  35. The first component of human complement (C1): activation and control.
    Springer Semin Immunopathol. 1983;6(2-3):213-30 PMID: 6314572
  36. Completion of the amino acid sequences of the A and B chains of subcomponent C1q of the first component of human complement.
    Biochem J. 1982 Jun 1;203(3):559-69 PMID: 6981411
  37. Unique role of the complement receptor CR1 in the degradation of C3b associated with immune complexes.
    J Exp Med. 1982 Dec 1;156(6):1739-54 PMID: 7175439
  38. Anaphylatoxin-mediated regulation of the immune response. II. C5a-mediated enhancement of human humoral and T cell-mediated immune responses.
    J Immunol. 1983 Mar;130(3):1257-61 PMID: 6600480
  39. Deficiency of an erythrocyte membrane protein with complement regulatory activity in paroxysmal nocturnal hemoglobinuria.
    Proc Natl Acad Sci U S A. 1983 Sep;80(17):5430-4 PMID: 6225118
  40. Inhibition of the reconstitution of the haemolytic activity of the first component of human complement by a pepsin-derived fragment of subcomponent C1q.
    Biochem J. 1977 Feb 1;161(2):239-45 PMID: 322655
  41. Identification of a C3bi-specific membrane complement receptor that is expressed on lymphocytes, monocytes, neutrophils, and erythrocytes.
    J Exp Med. 1982 Jan 1;155(1):96-110 PMID: 6915077
  42. The release of lysosomal enzymes from human polymorphonuclear leukocytes by human C3e.
    Clin Immunol Immunopathol. 1984 Feb;30(2):321-9 PMID: 6198120
  43. The role of C3 fragments in endocytosis and extracellular cytotoxic reactions by polymorphonuclear leukocytes.
    Clin Immunol Immunopathol. 1982 May;23(2):335-57 PMID: 7049467
  44. Augmentation of macrophage complement receptor function in vitro. III. C3b receptors that promote phagocytosis migrate within the plane of the macrophage plasma membrane.
    J Exp Med. 1981 Aug 1;154(2):291-305 PMID: 7264560
  45. Differential modulation of macrophage membrane markers by interferon: analysis of Fc and C3b receptors, Mac-1 and Ia antigen expression.
    J Interferon Res. 1983;3(2):153-60 PMID: 6192184
  46. Complement (C3) receptors on dendritic reticulum cells of normal and malignant lymphoid tissue.
    Clin Exp Immunol. 1982 May;48(2):348-52 PMID: 7049451
  47. Assay of membrane complement receptors (CR1 and CR2) with C3b- and C3d-coated fluorescent microspheres.
    J Immunol. 1982 Jan;128(1):186-9 PMID: 7033372
  48. Stimulation of murine B lymphocytes by isolated C3b.
    J Exp Med. 1975 Sep 1;142(3):600-10 PMID: 1100761
  49. An inherited abnormality of neutrophil adhesion. Its genetic transmission and its association with a missing protein.
    N Engl J Med. 1980 May 22;302(21):1163-8 PMID: 7366657
  50. Membrane distribution and adsorptive endocytosis by C3b receptors on human polymorphonuclear leukocytes.
    J Exp Med. 1981 Jun 1;153(6):1615-28 PMID: 7252422
  51. The biochemistry of complement.
    Nature. 1978 Oct 26;275(5682):699-704 PMID: 703835
  52. Characterization of a human B cell-specific antigen (B2) distinct from B1.
    J Immunol. 1981 May;126(5):1941-7 PMID: 6163824
  53. A rosette assay for the determination of C 1 q receptor-bearing cells.
    Eur J Immunol. 1979 Oct;9(10):797-801 PMID: 118036
  54. Competition for immune complexes by red cells in human blood.
    J Clin Lab Immunol. 1982 Jan;7(1):7-13 PMID: 7069779
  55. Characterization of the lymphocyte membrane receptor for factor H (beta 1H-globulin) with an antibody to anti-factor H idiotype.
    J Exp Med. 1982 May 1;155(5):1400-11 PMID: 6461713
  56. Anaphylatoxin-induced histamine release with human leukocytes: studies of C3a leukocyte binding and histamine release.
    J Clin Invest. 1979 Sep;64(3):804-11 PMID: 89118
  57. Receptors for immunoglobulin and complement on human alveolar macrophages.
    J Immunol. 1975 Jun;114(6):1813-9 PMID: 1127229
  58. Lysis of C1Q-coated chicken erythrocytes by human lymphoblastoid cell lines.
    J Immunol. 1978 Jan;120(1):27-32 PMID: 564373
  59. Identification of types of cells in human peripheral blood that bind C1q.
    J Immunol. 1981 Mar;126(3):1174-9 PMID: 6970220
  60. Interaction of target cell-bound C3bi and C3d with human lymphocyte receptors. Enhancement of antibody-mediated cellular cytotoxicity.
    J Exp Med. 1981 Jun 1;153(6):1592-603 PMID: 7252421
  61. Structure and function of the anaphylatoxins.
    Springer Semin Immunopathol. 1984;7(2-3):193-219 PMID: 6387982
  62. Demonstration of a specific receptor for human C5a anaphylatoxin on murine macrophages.
    J Exp Med. 1982 Jul 1;156(1):68-78 PMID: 7086356
  63. Dynamic aspects of the interaction between antibodies and complement at the cell surface.
    Scand J Immunol. 1974;3(3):237-50 PMID: 4211939
  64. Regulation of the amplification C3 convertase of human complement by an inhibitory protein isolated from human erythrocyte membrane.
    Proc Natl Acad Sci U S A. 1979 Nov;76(11):5867-71 PMID: 293688
  65. Identification of the membrane glycoprotein that is the C3b receptor of the human erythrocyte, polymorphonuclear leukocyte, B lymphocyte, and monocyte.
    J Exp Med. 1980 Jul 1;152(1):20-30 PMID: 6967510
  66. Anti-Mac-1 selectively inhibits the mouse and human type three complement receptor.
    J Exp Med. 1982 Oct 1;156(4):1000-9 PMID: 7153706
  67. Leucocyte mobilizing factor: a new biological activity derived from the third component of complement.
    Eur J Immunol. 1972 Dec;2(6):550-8 PMID: 4266011
  68. Complement receptor (CR1) deficiency in erythrocytes from patients with systemic lupus erythematosus.
    J Exp Med. 1982 May 1;155(5):1427-38 PMID: 6978375
  69. Immunohistochemical study of the human glomerular C3b receptor in normal kidney and in seventy-five cases of renal diseases: loss of C3b receptor antigen in focal hyalinosis and in proliferative nephritis of systemic lupus erythematosus.
    J Clin Invest. 1982 Apr;69(4):900-12 PMID: 7042757
  70. Ultrastructure of the human complement component, Clq (negative staining-glutamine synthetase-biologically active Clq).
    Proc Natl Acad Sci U S A. 1972 Jan;69(1):65-8 PMID: 4109599
  71. Identification of the membrane receptor for the complement fragment C3d by means of a monoclonal antibody.
    J Exp Med. 1983 Oct 1;158(4):1021-33 PMID: 6225820
  72. C3e: an acidic fragment of human C3 with leukocytosis-inducing activity.
    J Immunol. 1979 Aug;123(2):616-21 PMID: 110877
  73. Isolation and characterization of a C3b receptor-like molecule from membranes of a human B lymphoblastoid cell line (Raji).
    FEBS Lett. 1981 Dec 21;136(1):111-4 PMID: 6976275
  74. Release of histamine from rat mast cells by the complement peptides C3a and C5a.
    Immunology. 1975 Jun;28(6):1067-80 PMID: 48505
  75. Deficiency of a surface membrane glycoprotein (Mo1) in man.
    J Clin Invest. 1984 Jan;73(1):153-9 PMID: 6361068
  76. Identification of the C3bi receptor of human monocytes and macrophages by using monoclonal antibodies.
    Proc Natl Acad Sci U S A. 1983 Sep;80(18):5699-703 PMID: 6225125
  77. Induction of antibody-dependent and nonspecific tumor killing in human monocytic leukemia cells by nonlymphocyte factors and phorbol ester.
    Cell Immunol. 1982 Aug;71(2):215-23 PMID: 6754099
  78. Inhibition of phagocytosis of complement C3- or immunoglobulin G-coated particles and of C3bi binding by monoclonal antibodies to a monocyte-granulocyte membrane glycoprotein (Mol).
    J Clin Invest. 1983 Jul;72(1):171-9 PMID: 6874946
  79. Studies on the mechanism of phagocytosis. I. Requirements for circumferential attachment of particle-bound ligands to specific receptors on the macrophage plasma membrane.
    J Exp Med. 1975 Nov 1;142(5):1263-82 PMID: 1194852
  80. Qualitative and quantitative assessment of C3-receptor reactivities on lymphoid and phagocytic cells.
    J Immunol. 1981 May;126(5):2042-7 PMID: 7217681
  81. Structure and function of membrane complement receptors. Summary.
    Fed Proc. 1982 Dec;41(14):3089-93 PMID: 6982833
  82. C1q (c1) receptor on human platelets: inhibition of collagen-induced platelet aggregation by C1q (C1) molecules.
    J Immunol. 1976 Jul;117(1):304-9 PMID: 1084367
  83. C3d receptors are expressed on human monocytes after in vitro cultivation.
    Proc Natl Acad Sci U S A. 1983 Apr;80(8):2351-5 PMID: 6601277
  84. Complement (C3b) interaction with the human granulocyte receptor: correlation of binding of fluid-phase radiolabeled ligand with histaminase release.
    J Immunol. 1982 May;128(5):2313-8 PMID: 6801135
  85. beta 1H stimulates mouse-spleen B lymphocytes as demonstrated by increased thymidine incorporation and formation of B cell blasts.
    Immunobiology. 1981;160(3-4):289-301 PMID: 6459990
  86. Complement (C5-a)-induced granulocyte aggregation in vitro. A possible mechanism of complement-mediated leukostasis and leukopenia.
    J Clin Invest. 1977 Jul;60(1):260-4 PMID: 874088
  87. Expression of C3b receptors on human be cells and myelomonocytic cells but not natural killer cells.
    J Immunol. 1983 Apr;130(4):1668-73 PMID: 6220062
  88. Characterization of the human complement (c3b) receptor with a fluid phase C3b dimer.
    J Immunol. 1981 Oct;127(4):1348-54 PMID: 7276561
  89. Analysis of the different types of leukocyte membrane complement receptors and their interaction with the complement system.
    J Immunol Methods. 1980;37(3-4):197-211 PMID: 7005344
  90. Inhibition of complement by a substance isolated from human erythrocytes. II. Studies on the site and mechanism of action.
    Immunochemistry. 1969 May;6(3):405-19 PMID: 5786934
  91. Release of leukotrienes from guinea pig lung stimulated by C5ades Arg anaphylatoxin.
    J Immunol. 1982 May;128(5):2247-52 PMID: 6174625
  92. Modulation of human lymphocyte function by C3a and C3a(70-77).
    J Exp Med. 1982 Sep 1;156(3):756-65 PMID: 7050289
  93. Specificity of C3 receptors that mediate phagocytosis by rat peritoneal mast cells.
    J Immunol. 1981 Jun;126(6):2302-6 PMID: 6971894
  94. Clq inhibition of the interaction of collagen with human platelets.
    J Immunol. 1976 Jan;116(1):162-3 PMID: 1245737
  95. C1Q receptors on cultured human gingival fibroblasts: analysis of binding properties.
    J Immunol. 1983 Apr;130(4):1871-5 PMID: 6339617
  96. Molecular biology and chemistry of the alternative pathway of complement.
    Adv Immunol. 1980;29:1-53 PMID: 6158260
  97. Severe recurrent bacterial infections associated with defective adherence and chemotaxis in two patients with neutrophils deficient in a cell-associated glycoprotein.
    J Pediatr. 1982 Dec;101(6):932-40 PMID: 7143170
  98. Lack of binding of human C3, in its native state, to C3b receptors.
    J Immunol. 1981 Oct;127(4):1329-34 PMID: 7276560
  99. C1q protein of human complement.
    Biochemistry. 1972 Aug 29;11(18):3443-50 PMID: 4626765
  100. Structural homology of a macrophage differentiation antigen and an antigen involved in T-cell-mediated killing.
    Nature. 1982 Apr 15;296(5858):668-70 PMID: 6175907
  101. Fibronectin and serum amyloid P component stimulate C3b- and C3bi-mediated phagocytosis in cultured human monocytes.
    J Exp Med. 1983 Oct 1;158(4):1338-43 PMID: 6225825
  102. The binding of human complement proteins C5, factor B, beta 1H and properdin to complement fragment C3b on zymosan.
    Biochem J. 1981 Dec 1;199(3):485-96 PMID: 6462133
  103. Demonstration of specific C5a receptor on intact human polymorphonuclear leukocytes.
    Proc Natl Acad Sci U S A. 1978 Aug;75(8):3943-7 PMID: 279010
  104. Mode of inheritance of decreased C3b receptors on erythrocytes of patients with systemic lupus erythematosus.
    N Engl J Med. 1982 Oct 14;307(16):981-6 PMID: 7110302
  105. Suppression of T lymphocyte functions by human C3 fragments. I. Inhibition of human T cell proliferative responses by a kallikrein cleavage fragment of human iC3b.
    J Immunol. 1983 Jun;130(6):2605-11 PMID: 6602172
  106. Genetic regulation of a structural polymorphism of human C3b receptor.
    J Clin Invest. 1983 Aug;72(2):685-93 PMID: 6223944
  107. Leucoattractants enhance complement receptors on human phagocytic cells.
    Clin Exp Immunol. 1979 Nov;38(2):294-9 PMID: 527263
  108. Role of beta 1H for the binding of C3b-coated particles to human lymphoid and phagocytic cells.
    Eur J Immunol. 1981 Oct;11(10):739-45 PMID: 6458499
  109. Inhibition of complement by a substance isolated from human erythrocytes. I. Extraction from human erythrocyte stromata.
    Immunochemistry. 1969 May;6(3):391-403 PMID: 5786933
  110. Interaction of aggregated -globulin with B lymphocytes.
    J Exp Med. 1972 Jul 1;136(1):191-6 PMID: 4113510
  111. Analysis of receptor-mediated C1q binding to human peripheral blood mononuclear cells.
    J Immunol. 1980 Oct;125(4):1658-64 PMID: 7410850
  112. The role of membrane receptors for C3b and C3d in phagocytosis.
    J Exp Med. 1977 Feb 1;145(2):357-71 PMID: 833545
  113. Human C5a and C5a analogs as probes of the neutrophil C5a receptor.
    Mol Immunol. 1980 Feb;17(2):151-61 PMID: 6248769
  114. Anaphylatoxin-mediated contraction of guinea pig lung strips: a nonhistamine tissue response.
    J Immunol. 1981 Jun;126(6):2258-61 PMID: 6164725
  115. Enzymatic digestion of the first component of human complement (C1q).
    J Immunol. 1974 Jun;112(6):2094-101 PMID: 4363509
  116. Generation of three different fragments of bound C3 with purified factor I or serum. I. Requirements for factor H vs CR1 cofactor activity.
    J Immunol. 1982 Nov;129(5):2051-60 PMID: 6214588
  117. Regulation of immune response by components of the complement cascade and their activated fragments.
    Springer Semin Immunopathol. 1983;6(2-3):173-94 PMID: 6356429
  118. The human C3b receptor.
    Springer Semin Immunopathol. 1983;6(2-3):159-72 PMID: 6227098
  119. C3 receptors on human lymphocyte subsets and recruitment of ADCC effector cells by C3 fragments.
    J Immunol. 1983 Jun;130(6):2831-6 PMID: 6222118
  120. C3 modified at the thiolester site: acquisition of reactivity with cellular C3b receptors.
    Biosci Rep. 1981 Nov;1(11):873-80 PMID: 6458338
  121. Stimulation of a human polymorphonuclear leukocyte oxidative response by the C1q subunit of the first complement component.
    J Immunol. 1982 Jun;128(6):2547-52 PMID: 6281333
Article Info
Journal
Springer seminars in immunopathology
Abbr.
Springer Semin Immunopathol
ISSN
0344-4325
DOI
10.1007/BF01893021
Published
1984-00-00
Pages
221-49
Language
English
Region
Germany
NLM ID
7910384
Subset
IM
Grants
NIAID NIH HHS · AI 17354 · United States
NCI NIH HHS · CA 34120 · United States
External Links
PubMed source DOI: 10.1007/BF01893021
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com

Copyright © 2026.Genelibs Jinan Honghui Biotechnology Co., Ltd. 鲁ICP备20007159号-2